Early complications of primary total hip replacement for osteoarthritis – Between 2012 and 2016

Complicaciones postoperatorias tempranas en reemplazo primario de cadera por artrosis entre 2012-2016

Total hip arthroplasty (THA) is the surgical replacement of the anatomic components of the hip joint for a prosthesis. Survival rates of 95% (10 years) and 80% (more than 25 years) may be achieved. THA also provides significant benefits regarding pain, motion and function.
Objective: To describe the incidence of early postoperative complications in patients who underwent THA at the San José and Infantil Universitario de San José hospitals in Bogotá between January 2012 and June 2016.
Methodology: A descriptive retrospective study including patients aged 18 years or older who had THA. Those living abroad or having no contact information were excluded. Independent data analysis was conducted for each hip in bilateral THA.
Results: A total of 326 patients with 356 hips undergoing THA were analyzed. Median age was 64 (IQR 53-73), 67.79% were males, and 54.21% THA were performed on the right hip. Fifteen complications were identified, 14/356 (3.93%) had at least one complication. The most common complications were thromboembolic events (1.69%) followed by neurologic lesions (0.84%). No fractures were observed.
Conclusions: A low complication incidence after primary arthroplasty was evidenced. Complications were more frequent among those older than 65 years.

1. Liu YE, Hu S, Chan SP, Sathappan SS. The epidemiology and surgical outcomes of patients undergoing primary total hip replacement: an Asian perspective. Singapore Med J. 2009;50:15–9.

2. Alzahrani MM, Smith K, Tanzer D, Tanzer M. Primary total hip arthroplasty: Equivalent outcomes in low and high functioning patients. J Am Acad Orthop Surg. 2016;24: 814–22.

3. Kolundzic R, Trkulja V, Orlic D. History and factors of survival of total hip arthroplasty. Med Glas (Zenica). 2012;9:136–42.

4. Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet. 2007;370:1508–19. Publicación electrónica 30/10/2007.

5. Shan L, Shan B, Graham D, Saxena A. Total hip replacement: a systematic review and meta-analysis on mid-term quality of life. Osteoarthritis Cartilage. 2014;22:389–406.

6. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–5.

7. Smith GH, Johnson S, Ballantyne JA, Dunstan E, Brenkel IJ. Predictors of excellent early outcome after total hip arthroplasty. J Orthop Surg Res. 2012;7:13.

8. Enrique Páez R, Nossa JM, Rueda G, Pesantez R. Complicaciones tempranas en la artroplastia total primaria de la cadera. Experiencia Hospital de San José, Bogotá 2000-2005. Rev Colomb Ortop Traumatol. 2006;20:43–9.

9. Macaulay WB. Artroplastia total primaria de cadera. En: Fitzgerald RH, Kaufer H, Malkani AL, editores. Ortopedia. Argentina: Editorial Médica Panamericana; 2004.

10. Razuin R, Effat O, Shahidan MN, Shama DV, Miswan MF. Bone cement implantation syndrome. Malays J Pathol. 2013;35:87–90.

11. Huang A, Ryu JJ, Dervin G. Cost savings of outpatient versus standard inpatient total knee arthroplasty. Can J Surg. 2017;60:57–62.

12. Molloy IB, Martin BI, Moschetti WE, Jevsevar DS. Effects of the length of stay on the cost of total knee and total hip arthroplasty from 2002 to 2013. J Bone Joint Surg Am. 2017;99:402–7.

13. Sanchez-Sotelo J, Berry DJ. Epidemiology of instability after total hip replacement. Orthop Clin North Am. 2001;32:543–52, vii.

14. Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, et al. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. Arch Intern Med. 2001;161:1952–60. Publicación electrónica 26/09/2001.

15. Douketis JD, Eikelboom JW, Quinlan DJ, Willan AR, Crowther MA. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med. 2002;162:1465–71. Publicación electrónica 2/07/2002.

16. Callaghan J. Primary total hip arthroplasty: Indications and contraindications. 2 ed. New York: Raven press; 1993.

17. Nutt JL, Papanikolaou K, Kellett CF. (ii) Complications of total hip arthroplasty. Orthop Trauma. 2013;27:272–6.

18. Kapicioglu M, Ersen A, Saglam Y, Akgul T, Kizilkurt T, Yazicioglu O. Hip fractures in extremely old patients. J Orthop. 2014;11:136–41.

19. Garland A, Gordon M, Garellick G, Karrholm J, Skoldenberg O, Hailer NP. Risk of early mortality after cemented compared with cementless total hip arthroplasty: a nationwide matched cohort study. Bone Joint J. 2017;99-B:37–43.